Home - Boston Life Sciences Times

LATEST ARTICLES

Pharma

Exelixis Announces Detailed Phase 1b Results from Cohort 6 of COSMIC-021 Trial

Life Sciences Times - September 20, 20210

Pharma

SpectrumX’s SPC-069 Respiratory Treatment Shows Unprecedented Efficacy against Multiple Coronavirus Variants

Life Sciences Times - September 20, 20210

Pharma

Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years

Life Sciences Times - September 20, 20210

People on the Move

MedAvail Appoints Ramona Seabaugh as Chief Financial Officer

Life Sciences Times - September 20, 20210

Medtech

Medical-Grade ECG Now Available for ALL Consumer Wearable Devices

Life Sciences Times - September 17, 20210

People on the Move

First-Ever Executive Leadership Change Spells Next Era of Innovation for Twin Cities Health Plan Leader HealthEZ

Life Sciences Times - September 17, 20210

Medtech

CARMAT Receives Final Approval From the Patient Protection Committee for the Use of the Commercial Version of the Aeson® Heart in the EFICAS Study...

Life Sciences Times - September 17, 20210

Biotech

Spectrum Chemical Launches bioCERTIFIED™ Cleaning in Place Solutions

Life Sciences Times - September 17, 20210

Venture Capital

Hercules Capital Closes Public Offering of $325.0 Million 2.625% Notes due 2026

Life Sciences Times - September 17, 20210

Venture Capital

JSR Agrees to Acquire EUV Pioneer Inpria Corporation

Life Sciences Times - September 17, 20210

1...731732733...831 Page 732 of 831

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

May 1, 2026

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

May 1, 2026

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

May 1, 2026

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

May 1, 2026

Most Popular

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

Recent Comments

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Study Finds Masimo Pulse Oximetry Accurate Across Skin Tones in Newborns

Komodo Health Names Paul Thomas Chief Financial Officer

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

POPULAR CATEGORY

ABOUT US

FOLLOW US